A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Public ClinicalTrials.gov record NCT07668336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes
Study identification
- NCT ID
- NCT07668336
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Interventions
- Orforglipron Drug
- Dulaglutide Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026
- Primary completion
- Feb 28, 2030
- Completion
- Feb 28, 2030
- Last update posted
- Jul 19, 2026
2026 – 2030
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology | Sacramento | California | 95821 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| Stamford Therapeutics Consortium | Stamford | Connecticut | 06905 | — |
| Children's Healthcare of Atlanta - Center for Advanced Pediatrics (CAP) | Atlanta | Georgia | 30329 | — |
| CenExel iResearch, LLC | Decatur | Georgia | 30030 | — |
| Medical Research Partners | Ammon | Idaho | 83406 | — |
| Cotton O'Neil Diabetes & Endocrinology | Topeka | Kansas | 66606 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Advantage Clinical Trials | The Bronx | New York | 10467 | — |
| Central States Research | Tulsa | Oklahoma | 74136 | — |
| Frontier Clinical Research, LLC | Smithfield | Pennsylvania | 15478 | — |
| Vanderbilt Health One Hundred Oaks | Nashville | Tennessee | 37204 | — |
| Gadolin Research | Beaumont | Texas | 77702 | — |
| Driscoll Children's Hospital | Corpus Christi | Texas | 78411 | — |
| Proactive Clinical Research LLC | Edinburg | Texas | 78539 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| Victoria Clinical Research Group | Victoria | Texas | 77901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07668336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07668336 live on ClinicalTrials.gov.